Foundation for the NIH to Support Worldwide Competition Focused on Improving the Accuracy of Lung Cancer Screenings
The Foundation for the National Institutes of Health (FNIH) has been awarded a $2.4 million grant from the Laura and John Arnold Foundation (LJAF) to support a worldwide Coding for Cancer™ competition focused on improving the accuracy of lung cancer screenings. Inaccurate results, in the form of false positives, cause a considerable amount of stress for patients and may require them to spend money on costly follow-up screenings. The competition will be designed and coordinated by the NCI’s Cancer Imaging Program and will offer up to $1.8 million in prizes.
Photo courtesy of: Lawrence Schwartz, MD, Chair of Department of Radiology at Columbia University Medical Center
Read more >>
Donate and Support Today
Take Action to Support Life-Saving Medical Research
Every dollar counts! Your gift to the FNIH makes our efforts possible. With your help—and in partnership with NIH—the Foundation is advancing biomedical research and training.
Donate with Confidence
For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards.
News and Highlights
The FNIH Award Ceremony and presentation of the 2015 Lurie Prize in Biomedical Sciences will be held May 20, in Washington, D.C. Individual and table tickets are now available, as are sponsorship opportunities. Click here to learn more >>
FNIH has selected Karl Deisseroth, M.D., Ph.D., as the 2015 winner of the Lurie Prize in Biomedical Sciences for the development of optogenetics and CLARITY as tools to study the functions of cells, especially neurons. More >>
Mrs. Lily Safra, one of the lead benefactors who helped make the Edmond J. Safra Family Lodge possible, is funding renovations and enhancements to the home that families count on during their loved ones’ treatment at the NIH Clinical Center.
More >>The Foundation for the National Institutes of Health (FNIH) will award more than $3.5 million to further the study of Type 2 Diabetes (T2D) as part of an unprecedented collaboration to develop new ways to diagnose and treat several pressing diseases.
Read the study here >>